glp-1 receptor agonist long term side effects Your guide to long term side effects of
Description
AMPLITUDE-O compared efpeglenatide to placebo in 4076 adults with T2DM and previous CV events or CV risk factors only [8]
(2021) 22(Suppl 4):e13254
Your physician will help you decide
Structure may be low-res, but the chemistry
Beyond their metabolic benefits, growing evidence has highlighted their anti-inflammatory properties across a range of conditions characterized by chronic inflammation
The risk of hypoglycemia, or low blood sugar, is very low and usually only occurs in patients who take a GLP-1 medication with another medication that is known to cause hypoglycemia, such as insulin
